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Available online 5 November 2016AbstractIntroduction and objectives: To analyze postoperative complications and to assess for significant predictive factors during partial nephrec-
tomy (PN) using a large multicenter dataset.
Methods: Patients who underwent PN for clinical T1 renal tumors at 19 urological Italian centers (Registry of Conservative Renal Surgery
[RECORd] project) were evaluated between 2009 and 2012. Anthropometric data, comorbidities and perioperative outcomes were
analyzed. Complications were divided as intra- and postoperative, medical and surgical, as appropriate. The severity of postoperative com-
plications was graded according to the modified Clavien classification system. Patients who experienced intraoperative complications were
excluded from the analyses for the potential confounding effect in the evaluation of predicting factors for postoperative complications.
Results: Overall, 979 patients were analyzed: open, laparoscopic and robot-assisted (available since 2011) surgical approaches were used in 522
(56.4%), 286 (30.9%) and 117 (12.6%) cases, respectively. Surgical postoperative complications were reported in 121 (13.1%) cases (32 (3.5%)
wereClavien 3),medicalwere reported in 52 (5.6%) cases (3 (0.3%)wereClavien 3).NoClavien 4 complicationswere reported.Atmultivariable
analysis, ECOG score 1 (OR 1.98; p ¼ 0.002), lower preoperative hemoglobin (OR 0.71; p < 0.0001) and open surgical approach (2.91;
p¼ 0.02) were significant predictive factors of overall surgical postoperative complications, ECOG score1 (OR 1.93; p¼ 0.04) and surgical
approach (p ¼ 0.05) were significant predictive factors of Clavien 3 either surgical or medical postoperative complications.
Conclusions: Comorbidities and surgical approach should be considered in preoperative evaluation of patients undergoing PN, as they re-
sulted to play a significant role in the occurrence of postoperative complications.
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Renal cell carcinoma (RCC) diagnosis has increased
worldwide in both men and women because of higher use
of diagnostic imaging.1
Historically, partial nephrectomy (PN) was exclusive for
small renal masses or patients with reduced renal function,
but with advances of surgical skills, its indications have
broaden out to high-complex tumors such as hilar,
completely endophytic and clinical T1b renal masses.2,3
PN has been associated, in observational and retrospective
studies, with reduced mortality for cardiovascular accidents
compared to radical nephrectomy. Concurrently, postopera-
tive surgical complications represent the prominent concern
of PN, as they have been reported in up to 30% of cases,
with a major (Clavien 3e4) complication rate of 3e6%.4
Hemorrhagic complications caused by bleeding from the
healthy renal parenchyma represent common and poten-
tially life-threatening events, as they may require blood
transfusions and, in some cases, a radiologic maneuver or
a surgical reintervention. Urinary fistulas are often associ-
ated to the resection of endophytic renal masses, as a conse-
quence of a renal calyceal violation. Usually, they are
managed by a prolonged maintenance of abdominal drain
and, as second line of treatment, by ureteral stenting.5,6
Multiple factors have been variously reported as predic-
tive of surgical complications. These factors seem to be
dependent on patients’ clinical characteristics, nephrometry
parameters, surgical approach and technique.3,7
The aim of this study is to analyze postoperative compli-
cations of PN and to assess for significant predictive factors
in T1 renal tumors by the retrospective analysis of a pro-
spective multicentre cohort (RECORd1 Project).
Materials and methods
The Italian Registry of Conservative Renal Surgery (RE-
CORd Project) is a 4-year prospective observational multi-
centre study promoted by the Leading Urological No profit
foundation Advanced research (LUNA) of the Societa Ital-
iana di Urologia (SIU). The RECORd project includes all
patients who underwent conservative surgical treatment
for radiologically diagnosed renal cell carcinoma (RCC)
between January 2009 and December 2012 at 19 urological
Italian Centers, upon the approval of the study protocol by
the local ethical committee and patients’ acceptance of the
written informed consent.8
An online central data server was generated. It contains
anthropometric, preoperative, and imaging data, indications
and comorbidities, intra and post-operative data, histopath-
ological analysis. All data were prospectively recorded by
medical doctors. Surgical indications were defined as elec-
tive (localized unilateral RCC with healthy contralateral
kidney), relative (localized unilateral RCC with the coexis-
tence of comorbidities such as diabetes, hypertension or
lithiasis that could potentially affect kidney function inthe future) and absolute (bilateral tumors, multiple tumors,
moderate to severe CKD or tumors involving an anatomi-
cally or functionally solitary kidney).
Patients with uncontrolled diabetes at preoperative
exams were submitted either to the Diabetes center of the
referring hospital or the anesthesiologist in charge and
had their treatment changed to achieve a better control of
glycemia. Similarly, patients with uncontrolled hyperten-
sion had their treatment changed either by cardiologist or
anesthesiologist in charge.
Performance status was assigned according to the ECOG
criteria.9 In all patients, clinical workup included at least
abdominal computed tomography (CT) scan and chest X-
ray. Tumors were classified according to their location on
the longitudinal plane (upper pole, middle part, and lower
pole) and on the transverse plane (anterior surface, poste-
rior surface, lateral margin, medial margin, peri-hilar) of
the kidney. According to the degree of depth into the kid-
ney, each tumor was also classified into three growth
pattern categories: prevalently (50%) exophytic, preva-
lently endophytic (<50% exophytic), and entirely endo-
phytic. Centers were divided in low- and high-volume
according to the threshold of 50 PNs performed per year.
All intraoperative data including surgical approach and
technique, the decision whether to clamp the renal vessels,
type of ischemia, warm ischemia time (WIT), intraopera-
tive estimated blood loss (EBL) and operative time were re-
corded. The minimally invasive, laparoscopic or robot
assisted, and open approaches as well as the surgical tech-
nique, performed in the form of standard PN or simple
enucleation (SE), were adopted according to the centers’
and surgeons’ preference. Robot-assisted and laparoscopic
approaches were routinely done in 5 and 11 over 19 centers,
respectively. Surgeons were all skilled in performing either
robot-assisted, laparoscopic or open PN. Standard PN has
been defined as the excision of the tumor with a minimal
margin of healthy peritumoral renal parenchyma. SE has
been defined as the blunt tumor excision without removing
a visible rim of parenchymal tissue around the pseudocap-
sule.10 Hemoglobin, hematocrit, creatinine, and estimated
glomerular filtration rate (eGFR) by using modification of
diet in renal disease (MDRD) formula were recorded for
each patient preoperatively, in the first day and within the
first month postoperatively. Intraoperative complications
were defined as medical and/or surgical complications
occurring between induction of the anesthesia and patient
awakening that could potentially cause injury and require
unplanned medical or surgical maneuvers. Hospital stay
and postoperative complications occurring within 30 days
from surgery were recorded. Surgical postoperative compli-
cations were defined as any postoperative event caused by
surgery until the 30th postoperative day (POD), altering
the normal postoperative course and/or delaying discharge.
Medical postoperative complications were defined as any
postoperative event with no direct relation to surgery until
the 30th POD, altering the normal postoperative course
Table 1
Descriptive analysis of preoperative features.
Preoperative features
Center volume, n. % High 676 73.1%
Low 249 26.9%
Gender, n. % Male 600 64.9%
Female 325 35.1%
Age (yrs), mean SD 62.0 12.6
BMI (kg/m2), median IQR 26.0 24.1e28.4
Uncontrolled diabetes, n. (%) No 885 95,7%
Yes 40 4,3%
Uncontrolled hypertension,
n. (%)
No 808 87,4%
Yes 117 12,6%
ECOG, n. % 0 637 68.9%
1 288 31.1%
Indication, n. % Elective 736 79.6%
Relative 127 13.7%
Absolute 62 6.7%
Tumor side, n. % Right 492 53.2%
Left 433 46.8%
Clinical diameter, mean SD (cm) 3.2 1.3
Clinical diameter, median IQR (cm) 3.0 2.0e4.0
Clinical T, n. % T1a 740 80.0%
T1b 185 20.0%
Tumor site, n. % Polar sup. 261 28.2%
Mesorenal 375 40.5%
Polar inf. 289 31.2%
Tumor growth pattern, n. % 50% Exophytic 692 74.8%
<50% Exophytic 207 22.4%
Entirely endophytic 26 2.8%
Tumor localization, n. % Peri-hilar 49 5.2%
Anterior face 270 29.1%
Posterior face 257 27.7%
Medial margin 81 8.6%
Lateral margin 268 28.9%
Multiple lesions, n. % No 879 95.0%
Yes 46 5.0%
Preoperative hemoglobin (mg/dl), mean SD 14.1 1.4
Preoperative eGFR (ml/min/1.73 m2), median IQR 82.3 69.7e97.4
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was graded according to the modified Clavien classification
system.6 The ten Martin’s criteria for accurate and compre-
hensive reporting of surgical complications11 and the Euro-
pean Association of Urology (EAU) standardized quality
criteria on reporting PN surgical complications were
applied.12
For the purpose of the study, only patients with clinical
T1 (7 cm diameter at radiological diagnosis) renal tumors
were included. Furthermore, patients who experienced in-
traoperative complications were excluded from the data an-
alyses for their potential confounding effect in the
evaluation of preoperative and intraoperative risk factors
for postoperative complications.
Categorical variables were reported as frequencies and
proportions. Continuous variables were considered para-
metric or not parametric basing on kurtosis and skewness
values and, therefore, reported as mean and standard devi-
ation (SD) or as median and interquartile range (IQR), as
appropriate. The Student t test and the ManneWhitney U
test were used to compare continuous to categorical vari-
ables and the Pearson’s chi square test was used to compare
two categorical variables. A logistic regression was used to
make multivariable analyses. Statistical significance was set
as p  0.05. All reported p values were two-sided. Analyses
were carried out with SPSS version 20.0 (SPSS Inc, Chi-
cago, IL, USA).
Results
Overall, 979 patients were included in the dataset. For
the purpose of the study, 14 cases of clinical T2 renal tu-
mors, as well as 40 cases who experienced intraoperative
complications were excluded. Preoperative features of
925 patients are summarized in Table 1. Overall, 676
(73.1%) patients were treated in high volume centers, me-
dian body mass index (BMI) was 26.0 (IQR 24.1e28.4)
kg/m2, ECOG score was 1 in 288 (31.1%) cases. Surgical
indication was elective in 736 (79.6%) patients, relative in
127 (13.7%) and absolute in 62 (6.7%). Mean clinical tu-
mor diameter was 3.2 (SD 1.3) cm and 185 (20.0%) cases
were clinical T1b.
Surgical and postoperative features are summarized in
Table 2. Open PN (OPN) was performed in 522 (56.4%)
cases, laparoscopic (LPN) in 286 (30.9%) cases and
robot-assisted (RAPN), available since 2011, in 117
(12.6%) cases. SE technique was performed in 374
(40.4%) cases and standard PN technique in 551 (59.6%)
cases. Surgical postoperative complications were reported
in 121 (13.1%) cases: 78 (8.4%) hemorrhages treated by
transfusions (Clavien 2), 4 (0.4%) treated by superselective
embolization (Cl 3), 10 (1.0%) by surgical reinterventions
for bleeding (Clavien 3), 5 (0.5%) urinary fistulas managed
by drain manipulation (Clavien 1) and 20 (2.1%) treated by
stenting (Clavien 3), 5 (0.5%) acute renal failures caused by
prolonged WIT (Clavien 1), 1 (0.1%) pneumothorax treatedwith pleural drainage (Clavien 3)and 1 (0.1%) bowel sub-
occlusion (Clavien 1). Overall, 75 (8.1%) surgical postoper-
ative complications were Clavien 2 and 32 (3.5%) were
Clavien 3. No surgical Clavien 4e5 grade complications
were recorded. Medical postoperative complications were
reported in 52 (5.6%) cases. Clavien 1e2 medical compli-
cations (5.3%) were respiratory in 26 cases (2.7%) (16
pneumonias, 4 acute respiratory distress syndromes, 5
pleural effusions, 1 pulmonary hypertension), cardiologic
in 18 (1.8%) cases (5 ischemic events, 11 arrhythmias, 2
hypertensive crisis), one deep venous thrombosis (0.1%)
and from other causes in 7 (0.7%) patients. All three Clav-
ien 3 medical complications (0.3%) were respiratory: 2
pneumothoraxes treated by pleural drainage and 1 acute
respiratory distress syndrome treated by tracheal intubation.
Positive surgical margins were reported in 41 (5.5%) over
740 malignant tumors.
We assessed pre- and intra-operative variables related to
overall and Clavien 3 surgical postoperative complications
(Tables 3 and 4). At univariate analysis uncontrolled
Table 2
Descriptive analysis of surgical postoperative and histological features.
Surgical and postoperative features
Approach, n. % Open 522 56.4%
VLP 286 30.9%
Robot 117 12.6%
Technique, n. % Simple enucleation 374 40.4%
Standard PN 551 59.6%
Hilar clamping, n. % Not performed 335 36.2%
Performed 590 63.8%
Ischemia time (min), median IQR 16.0 12.0e20.0
EBL (cc), median IQR 150 100e250
Operative time (min), median IQR 130 105e170
Length of stay (days), median (IQR) 6.0 4.0e7.0
Preop-1st day D hemoglobin (mg/dl), mean SD 2.0 1.4
Preop-3rd day D hemoglobin (mg/dl), mean SD 2.7 1.5
Preop-3rd day D eGFR, median (IQR) 10.2 0e23.6
Preop-30th day D eGFR, median (IQR) 8.9 0e21.4
Surgical complications, n (%) 121 13.1%
 Transfusions, n. % 78 8.4%
 Superselective embolization, n. % 4 0.4%
 Surgical reintervention (bleeding), n. % 10 1.0%
 Urinary fistula treated without stenting, n. % 5 0.5%
 Urinary fistula treated with stenting, n. % 20 2.1%
 Acute renal failure, n. % 5 0.5%
 Pneumothorax treated with drainage, n. % 1 0.1%
 Intestinal subocclusion, n. % 1 0.1%
Surgical Clavien 2, n. % 86 9.3%
Surgical Clavien 3, n. % 34 3.5%
Medical complications, n (%) 52 5.6%
 Respiratory complications, n. % 29 3.2%
 Cardiologic complications, n. % 18 1.9%
 Deep venous thrombosis, n. % 1 0.1%
 Others medical complications, n. % 7 0.7%
Surgical margins, n (% in malignant tumors) Negative 699 94.5%
Positive 41 5.5%
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indication, clinical diameter (continuous variable), lower
preoperative hemoglobin and eGFR, low volume center
and OPN were significant predictive factors of overall sur-
gical postoperative complications. At multivariable analysis
ECOG score 1 (OR 1.85; CI 1.20e2.85; p ¼ 0.01), lower
preoperative hemoglobin (OR 0.73; CI 0.63e0.84;
p > 0.0001), and open surgical approach (OR 2.79; CI
1.15e6.76;p ¼ 0.02) were confirmed as significant and in-
dependent predictive factors of overall surgical postopera-
tive complications. At univariate analysis ECOG score
1, OPN were significant predictive factors of Clavien 3
surgical and medical postoperative complications. At multi-
variable analysis ECOG score 1 (OR 1.93; CI 0.95e4.03;
p ¼ 0.04) and surgical approach (p ¼ 0.05) were confirmed
to be independent factors of Clavien 3 surgical postopera-
tive complications.
Discussion
The indications for PN have expanded, over the past
decade, in comparison to radical nephrectomy (RN),because of comparable oncological and improved func-
tional outcomes along with a better long-term survival
due to reduced mortality for cardiovascular accidents.13
Conversely, the European Organization for Research and
Treatment of Cancer (EORTC) trial 30904 demonstrates
that PN seems to be significantly less effective than RN
in terms of overall survival and several studies reported a
significantly higher postoperative complication rates of
PN in complex renal masses and/or comorbid patients.14
To date, the controversial opinions about the risk/benefit
ratio of both PN and RN along with the clinical features of
each patient often influenced the treatment decision for
localized RCC.
The present analysis examined a contemporary, prospec-
tively recorded, series of almost a thousand consecutive pa-
tients who underwent open, laparoscopic or robotic PN in
19 Italian centers and showed a pan view on the incidence
and type of surgical and clinical complications that may
occur after surgery.
Indeed, postoperative surgical complications represent
the prominent concern of PN, as they have been descripted
in up to 30% of historical series, with a major complication
Table 3
Univariate and multivariate analysis for overall surgical postoperative complications.
Preoperative and surgical variables Univariable analysis for surgical complications Multivariable analysis for surgical
complications
No compl Compl p OR CI 95% p
ECOG, n. (%) 0 574 (90.1%) 63 (9.9%) < 0.0001 e e 0.01
1 230 (70.9%) 58 (20.1%) 1.85 1.20e2.85
Age, mean (SD) 61.7 (12,6) 63.1 (13.2) 0.19
BMI, median (IQR) 26.0 (24.1e28.4) 26.2 (24.1e28.4) 0.53
Uncontrolled diabetes, n. (%) No 775 (87.6%) 110 (12.4%) 0.01 e e 0.32
Yes 29 (72.5%) 11 (27.5%) 1.55 0.66e3.65
Uncontrolled hypertension, n. (%) No 707 (87.5%) 101 (12.5%) 0.17
Yes 97 (82.9%) 20 (17.1%)
Indication, n. (%) <0.0001 0.11
Elective 657 (89.3%) 79 (10.7%) e e e
Relative 104 (81.9%) 23 (18.1%) 1,56 0.86e2.86 0.18
Absolute 43 (69.4%) 19 (30.6%) 2.05 1.05e4.01 0.09
Clinical diameter, mean (SD) 3.1 (1.3) 3.5 (1.3) 0.01 1.13 0.98e1.31 0.10
Tumor site, n. (%) Polar sup. 227 (87.0%) 34 (13.0%) 0.67
Mesorenal 322 (85.9%) 53 (14.1%)
Polar inf. 255 (88.2%) 34 (11.8%)
Tumor growth pattern, n. (%) 50% Exoph 605 (87.4%) 87 (12.6%) 0.29
<50% Exoph 179 (86.5%) 28 (13.5%)
Tot endoph 20 (76.9%) 6 (23.1%)
Preoperative hemoglobin, mean (SD) 14.2 (1.3) 13.4 (1.6) <0.0001 0.73 0.63e0.84 <0.0001
Preoperative eGFR, median (IQR) 84.1 (70.5e99.1) 77.9 (63.6e92.4) 0.003 0.99 0.98e1.01 0.74
Center volume, n. (%) High 599 (88.6%) 77 (11.4%) 0.01 e e 0.12
Low 205 (82.3%) 44 (17.7%) 1,46 0.91e2.33
Approach, n. (%) <0.0001 0.01
Open 431 (82.6%) 91 (17.4%) 2,79 1.15e6.76 0.02
Laparoscopic 262 (91.6%) 24 (8.4%) 1,57 0.61e4.03 0.39
Robot-assisted 111 (94.9%) 6 (5.1%) e e e
Technique, n. % SE 327 (87.4%) 47 (12.6%) 0.70
PN 477 (86.6%) 74 (13.4%)
Ischemia time (min), median (IQR) 16.0 (13.0e21.0) 16.5 (12.0e21.0) 0.12
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some surgical complication, as shown by the large adoption
of hemostatic agents in spite of a clear evidence of their
usefulness.16
In the present study, overall and major surgical postop-
erative complications were reported in 13.1% and 3.5%
of cases, respectively. The presence of comorbidity
(analyzed as ECOG 1), lower preoperative hemoglobin
and the open surgical approach resulted as significant and
independent predictive factors of the development of over-
all surgical postoperative complications. Conversely, age,
BMI, uncontrolled hypertension and diabetes corrected
pre-operatively, nephrometry parameters, surgical indica-
tion and surgical technique did not.
Conflicting results have been reported in the literature
about the influence of comorbidities and performance sta-
tus, variously recorded using the Charlson’s comorbidity
index (CCI), the age adjusted CCI, or the ECOG score,
on surgical complications. Larcher et al. reported that
CCI is a significant predicting factor (OR: 1.14,
p < 0.001) of surgical complications, as well as age, tumor
diameter, previous acute kidney injury, tumor size and open
surgical approach in over 1962 patients treated for T1aRCC.15 Conversely, in other studies comorbidity, reported
as CCI, age adjusted CCI and the American Society of An-
esthesiologists (ASA) physical status classification system,
was not reported as significant predictive factors of
complications.4,7,17
The evaluation of performance status in the present se-
ries showed that patients with ECOG 1 have a 1.85-
and a 1.93-fold significant risk of development of overall
and Clavien 3 surgical complications, respectively. More-
over, higher level of serum hemoglobin revealed to be sig-
nificant protective factor with occurrence of overall surgical
complications. These results may confirm the indication of
performing RN in comorbid and weak patients to reduce
the risk of complications, but, on the other hand, PN can
be justified by the theoretical benefit of avoiding long-
term decrease of renal function, that in this cohort of pa-
tients may be even more important in order to increase
overall survival.
RAPN might represent a viable alternative to OPN in
this subgroup of patients for its protective effect from com-
plications. Indeed, in our series, we had the opportunity to
evaluate together the potential effects on complications of
OPN, LPN and RAPN. OPN was performed in all of the
Table 4
Univariate and multivariate analysis for Clavien 3 surgical and medical postoperative complications.
Preoperative and surgical variables Univariable analysis for surgical and medical
Clavien 3 complications
Multivariable analysis for Clav 3
complications
No compl Compl p OR CI 95% p
ECOG, n. (%) 0 621 (97.5%) 16 (2.5%) 0.03 e e 0.04
1 269 (93.4%) 19 (6.6%) 1.93 0.95e4.03
Age, mean (SD) 61.8 (12.6) 64.2 (14.6) 0.36
BMI, median (IQR) 26.0 (24.1e28.4) 26.8 (24.1e29.8) 0.28
Uncontrolled diabetes, n. (%) No 852 (96.2%) 34 (3.8%) 0.73
Yes 39 (97.5%) 1 (2.5%)
Uncontrolled hypertension, n. (%) No 777 (96.2%) 32 (3.9%) 0.57
Yes 114 (97.4%) 3 (2.6%)
Indication, n. (%) Elective 712 (96.5%) 26 (3.5%) 0.36
Relative 123 (96.9%) 4 (3.1%)
Absolute 57 (91.9%) 5 (8.1%)
Clinical diameter, mean (SD) 3.2 (1.3) 3.3 (1.3) 0.51
Tumor site, n. (%) Polar sup. 253 (97.3%) 8 (2.7%) 0.34
Mesorenal 357 (95.5%) 18 (4.5%)
Polar inf. 280 (97.2%) 9 (2.8%)
Tumor growth pattern, n. (%) 50% Exo 253 (92.7%) 20 (7.3%) 0.10
<50% Exo 194 (93.7%) 13 (6.3%)
Tot endo 24 (92.3%) 2 (7.7%)
Preoperative hemoglobin, mean (SD) 14.1 (1.4) 13.8 (1.2) 0.24
Preoperative eGFR, median (IQR) 83.1 (69.9e97.5) 76.8 (69.3e88.7) 0.20
Centre volume, n. (%) High 655 (96.6%) 23 (3.4%)
Low 235 (94.0%) 15 (6.0%)
Approach, n. (%) 0.03 0.05
Open 495 (94.3%) 30 (5.7%) 5,65 1.79e21.91 0.07
Laparoscopic 279 (97.9%) 7 (2.1%) 2,41 0.98e12.37 0.41
Robot-assisted 116 (99.1%) 1 (0.9%) e e e
Technique, n. % Simple enucleation 355 (94.4%) 21 (5.6%) 0.13
Standard PN 535 (96.9%) 17 (3.1%)
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it was used since the beginning of the study, while RAPN
was available in five high volume centers only in the last
two years of data collection.8 All surgeons were skilled
in each of the three approaches performed: the choice
among the approaches was primarily based on the avail-
ability of the technologies in the centres involved, but
also on the surgeons’ skills and experience. The different
preoperative features, as comorbidity and the anatomical
features of the tumors between the three approaches, might
represent a possible bias in the analyses. Therefore, we
performed accurate statistical analyses including important
patients’ and tumors’ related factors that confirmed that the
open surgical approach was strongly and independently
associated with the development of postoperative surgical
complications (Tables 3 and 4). In detail, OPN was associ-
ated with a nearly three-fold risk of overall postoperative
surgical complications in comparison with RAPN and sur-
gical approach was a significant and independent predict-
ing factor of major complications (Clavien 3 surgical and
medical complications). These results agree with a large
retrospective study by Ghani et al., which analyzed the
postoperative outcomes in patients submitted to PN in
US from 2008 to 2012 and showed that RAPN and LPN
were significantly associated with a lower risk of overallpostoperative complications and transfusion rate compared
to OPN.18 A possible explanations being the benefits of
minimally invasive surgery in addition to the improved
dexterity and vision of robotic system that makes open sur-
gery actions replicable and more precise with a robotic
approach.
The surgical technique adopted, has been reported to
have a potential effect on the development of surgical post-
operative complications for the protective role of SE with a
decreased rate of entry into the renal sinus and of calyceal
injuries, as long as a reduced need for tumor bed suturing
and a reduced warm ischemia time.10,19
On the contrary, the present study did not show any pro-
tective role of SE on surgical postoperative complications.
Several explanations can be provided: first, the surgical
technique was not recorded using the SIB margin score, a
newly developed system that aims to standardize the report-
ing of surgical techniques,20 while all data were registered
according to the surgeon-intention. Furthermore, the advan-
tages of SE could be more evident in a subgroup of patients
with large endophytic tumors instead of in the entire series
that included also a substantial number of cortical lesions
where the removal of a subtle rim of normal parenchyma
may not injury main parenchymal vessels or calyceal
system.3
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might significantly predict the risk of complications.7,4,21
However, Desantis et al. suggested that some clinical tumor
features included in the nephrometry scores, such as clin-
ical diameter and endophytic growth pattern, seem more
predictive of complications than others do.22 In the present
study, nephrometry scores were not reported as they had
been introduced in literature after the generation of this pro-
spective database (2008). Nevertheless, all nephrometry tu-
mor features, such as clinical diameter, growth pattern,
polar site, localization including hilar location and side,
were descripted and none of these significantly predicts sur-
gical complications. Moreover, we performed a uni- and
multi-variable analysis with a modified PADUA score,
which included all anatomical features but urinary calyceal
system compression or invasion. This score did not signif-
icantly influence the incidence of overall surgical and major
surgical and medical postoperative complications both as a
continuous and as a divided risk class groups while the
other variables did not change their significance at multi-
variable analysis (Results not showed).
This study is not devoid of limitations: cases were done
by a wide set of surgeons in different centers: all surgeons
were skilled in the approach performed. However, this
might have increased the external reproducibility of the
data with respect to a single-center or single-surgeon
setting. As above mentioned, nephrometry scores were
not reported. Despite these limitations, this study offers a
wide report of perioperative features from a large multi-
center prospectively recorded dataset of PN, performed
either with open, laparoscopic and robot-assisted approach.
Finally, the report of complications fulfilled the EAU stan-
dardized quality criteria.
In conclusion, the presence of comorbidities have to be
weighted in the preoperative assessment of patients candi-
date to PN, as it was found to be significantly associated
to overall and major surgical complications. Moreover,
minimally invasive approach should be preferred, whenever
possible, to avoid the risk of surgical complications.
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